PTCT logo

PTC Therapeutics (PTCT) Operating Expenses

Annual Operating Expenses

$1.22 B
+$127.69 M+11.67%

31 December 2023

PTCT Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$237.90 M
+$33.37 M+16.32%

30 September 2024

PTCT Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PTCT Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.7%-21.7%
3 y3 years+60.8%+10.9%
5 y5 years+250.7%+99.3%

PTCT Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+60.8%-26.1%+16.3%
5 y5 yearsat high+250.7%-26.1%+99.3%
alltimeall timeat high+2097.9%-26.1%+1890.4%

PTC Therapeutics Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$237.90 M(+16.3%)
June 2024
-
$204.53 M(-15.1%)
Mar 2024
-
$240.93 M(-12.3%)
Dec 2023
$1.22 B(+11.7%)
$274.82 M(-9.5%)
Sept 2023
-
$303.75 M(-5.6%)
June 2023
-
$321.72 M(+0.1%)
Mar 2023
-
$321.45 M(+1.3%)
Dec 2022
$1.09 B(+24.2%)
$317.18 M(+14.7%)
Sept 2022
-
$276.60 M(+5.0%)
June 2022
-
$263.45 M(+11.2%)
Mar 2022
-
$236.82 M(-6.3%)
Dec 2021
$881.21 M(+16.0%)
$252.73 M(+17.8%)
Sept 2021
-
$214.48 M(+3.6%)
June 2021
-
$207.11 M(+0.1%)
Mar 2021
-
$206.89 M(+1.4%)
Dec 2020
$759.70 M(+55.8%)
$204.05 M(+27.2%)
Sept 2020
-
$160.47 M(-32.8%)
June 2020
-
$238.91 M(+52.9%)
Mar 2020
-
$156.26 M(+1.9%)
Dec 2019
$487.64 M(+40.0%)
$153.30 M(+28.4%)
Sept 2019
-
$119.39 M(+3.1%)
June 2019
-
$115.77 M(+16.7%)
Mar 2019
-
$99.19 M(-8.5%)
Dec 2018
$348.41 M
$108.38 M(+10.0%)
Sept 2018
-
$98.53 M(+37.3%)
June 2018
-
$71.75 M(+2.8%)
DateAnnualQuarterly
Mar 2018
-
$69.76 M(-0.5%)
Dec 2017
$254.11 M(+18.3%)
$70.14 M(-1.4%)
Sept 2017
-
$71.16 M(+19.2%)
June 2017
-
$59.70 M(+12.9%)
Mar 2017
-
$52.86 M(+5.3%)
Dec 2016
$214.76 M(+5.3%)
$50.18 M(-8.8%)
Sept 2016
-
$55.05 M(+5.5%)
June 2016
-
$52.19 M(-9.0%)
Mar 2016
-
$57.34 M(-5.9%)
Dec 2015
$203.90 M(+63.6%)
$60.94 M(+17.2%)
Sept 2015
-
$52.01 M(+14.6%)
June 2015
-
$45.40 M(-0.3%)
Mar 2015
-
$45.55 M(-1.2%)
Dec 2014
$124.66 M(+55.6%)
$46.11 M(+62.4%)
Sept 2014
-
$28.40 M(+6.0%)
June 2014
-
$26.79 M(+14.7%)
Mar 2014
-
$23.36 M(-8.0%)
Dec 2013
$80.09 M(+44.1%)
$25.39 M(+28.7%)
Sept 2013
-
$19.73 M(-2.9%)
June 2013
-
$20.32 M(+38.7%)
Mar 2013
-
$14.65 M(+22.5%)
Dec 2012
$55.59 M(-18.7%)
$11.95 M(-8.7%)
Sept 2012
-
$13.10 M(-3.4%)
June 2012
-
$13.56 M(-20.1%)
Mar 2012
-
$16.97 M
Dec 2011
$68.38 M
-

FAQ

  • What is PTC Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for PTC Therapeutics?
  • What is PTC Therapeutics annual operating expenses year-on-year change?
  • What is PTC Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for PTC Therapeutics?
  • What is PTC Therapeutics quarterly operating expenses year-on-year change?

What is PTC Therapeutics annual total operating expenses?

The current annual operating expenses of PTCT is $1.22 B

What is the all time high annual operating expenses for PTC Therapeutics?

PTC Therapeutics all-time high annual total operating expenses is $1.22 B

What is PTC Therapeutics annual operating expenses year-on-year change?

Over the past year, PTCT annual total operating expenses has changed by +$127.69 M (+11.67%)

What is PTC Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of PTCT is $237.90 M

What is the all time high quarterly operating expenses for PTC Therapeutics?

PTC Therapeutics all-time high quarterly total operating expenses is $321.72 M

What is PTC Therapeutics quarterly operating expenses year-on-year change?

Over the past year, PTCT quarterly total operating expenses has changed by -$65.84 M (-21.68%)